NEW YORK (
) hit a new 52-week high Monday as it traded at $83.22 compared with its previous 52-Week high of $83.09. Beckman Coulter is changing hands at $83.16 with 248,449 shares traded as of 10:11 a.m. ET. Average volume has been 2.2 million shares over the past 30 days.
Beckman Coulter has a market cap of $5.9 billion and is part of the
industry. Shares are up 10.2% year to date as of the close of trading on Friday.
Beckman Coulter, Inc. provides biomedical testing instrument systems, tests, and supplies for clinical laboratories worldwide. The company has a P/E ratio of 25.5, equal to the average electronics industry P/E ratio and above the S&P 500 P/E ratio of 22.6.
TheStreet Ratings rates Beckman Coulter as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, good cash flow from operations and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full
52-week high stocks
or get investment ideas from our